Medical Xpress July 29, 2021
Institute for Research in Biomedicine (IRB Barcelona)

The Biomedical Genomics laboratory at IRB Barcelona has developed a computational tool that identifies cancer driver mutations for each tumor type.

This and other developments produced by the same lab seek to accelerate research and provide tools to help oncologists choose the best treatment for each patient.

The study has been published in the journal Nature.

Each tumor—each patient—accumulates many mutations, but not all of them are relevant for the of cancer. Researchers led by ICREA researcher Dr. Núria López-Bigas at IRB Barcelona have developed a tool, based on machine-learning methods, that evaluates the potential contribution of all possible mutations in a gene in a given type of tumor to the development and progression of cancer.

In previous...

Today's Sponsors

Transcarent
SalesSparx
Canton & Company

Today's Sponsors

Oscar
Curation Health

Today's Sponsor

TripleTree

 
Topics: AI (Artificial Intelligence), Pharma / Biotech, Precision Medicine, Provider, Technology
Sorcero Raises $10M for AI-Powered Medical Language Intelligence Platform
Unlocking healthcare with AI
AI: Clinician’s Friend or Foe?
How Virtual Assistants and Artificial Intelligence Can Help Ensure Patient Information Is Secure – and Streamline Operations
Artificial Intelligence could minimize damage from a growing nursing shortage